| For: | Kamrul-Hasan ABM, Dutta D, Nagendra L, Basavarajappa SD, Girijashankar HB, Joshi A, Pappachan JM. Glycemic control, weight-loss effects, and safety of cotadutide in individuals with type 2 diabetes: A systematic review and meta-analysis. World J Diabetes 2025; 16(12): 112830 [PMID: 41480597 DOI: 10.4239/wjd.v16.i12.112830] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i12/112830.htm |
| Number | Citing Articles |
| 1 |
Mehmet Kanbay, Sidar Copur, Giovambattista Capasso, Kultigin Turkmen, Pierre Delanaye, Annette Bruchfeld, Samar Abd ElHafeez, Charles J Ferro, Marianne C Verhaar, Francesco Pesce, Vassilios Liakopoulos, Peter Boor, Marcin Adamczak, Marina Vivarelli, Juan F Navarro-González, Rafael Kramann, Sandrine Florquin, Jose Manuel Valdieso. The evolving field of nephrology: what comes next? A report from the European Renal Association Scientific Advisory Board. Clinical Kidney Journal 2026; 19(5) doi: 10.1093/ckj/sfag136
|
| 2 |
A. B. M. Kamrul‐Hasan, Subhankar Chatterjee, Hamid Ashraf, Lakshmi Nagendra, Ibrahim Khalil, Mehedi Hasan, Alvee Ahsan, Deep Dutta. Efficacy and Safety of the Dual Glucagon‐Like Peptide‐1 and Glucagon Receptor Agonist Mazdutide in Predominantly Chinese Adults With Obesity and/or Type 2 Diabetes: A Systematic Review and Meta‐Analysis. Diabetes, Obesity and Metabolism 2026; doi: 10.1111/dom.71058
|